A1(OH)3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background

被引:41
作者
Authier, FJ
Sauvat, S
Christov, C
Chariot, P
Raisbeck, G
Poron, MF
Yiou, F
Gherardi, R
机构
[1] CHU Henri Mondor, AP HP, Ctr Reference Malad Neuromusculaires, F-94010 Creteil, France
[2] Fac Med Creteil Paris 12, INSERM E 0011, Creteil, France
[3] Ctr Spectrometrie Nucl & Spectrometrie Masse, CNRS, IN2P3, Orsay, France
关键词
inflammatory myopathies; macrophagic myofasciitis; experimental model; aluminium hydroxide; vaccine; adverse effects; histopathology; morphometry; Th1; Th2; radioisotopic study; Sprague-Dawley rat; Lewis rat;
D O I
10.1016/j.nmd.2006.02.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Macrophagic myofasciitis (MMF) is a specific histopathologic lesion involved in the persistence for years of aluminum hydroxide [AI(OH)(3)] at the site of previous intramuscular (i.m.) injection. In order to study mechanisms involved persistence of MMF lesions, we set up an experimental model of MMF-lesion in Sprague-Dawley and Lewis rat, by i.m. injections of 10 mu L of an Al(OH)(3)-adjuvanted vaccine. An evaluation carried out over a 12-month period disclosed significant shrinkage of MMF lesions with time. A radioisotopic study did not show significant aluminium uptake by AI(OH)(3)-loaded macrophages. A morphometric approach showed that Lewis rats with Th1-biased immunity had significantly smaller lesions than Sprague-Dawley rats with balanced Th1/Th2 immunity. Concluding, our results indicate that genetic determinatives of cytotoxic T-cell responses could interfere with the clearance process and condition the persistence of vaccine-induced MMF-lesions. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:347 / 352
页数:6
相关论文
共 34 条
[1]   Chronic fatigue syndrome in patients with macrophagic myofasciitis [J].
Authier, FJ ;
Sauvat, S ;
Champey, J ;
Drogou, I ;
Coquet, M ;
Gherardi, RK .
ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :569-570
[2]  
BALOUET G, 1977, ANN ANAT PATHOL, V22, P159
[3]   Inflammatory myopathy with abundant macrophages (IMAM): A condition sharing similarities with cytophagic histiocytic panniculitis and distinct from macrophagic myofasciitis [J].
Bassez, G ;
Authier, FJ ;
Lechapt-Zalcman, E ;
Delfau-Larue, MH ;
Plonquet, A ;
Coquet, M ;
Illa, I ;
Gherardi, RK .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (05) :464-474
[4]  
Brewer JM, 1999, J IMMUNOL, V163, P6448
[5]  
Chérin P, 2000, ARTHRITIS RHEUM-US, V43, P1520, DOI 10.1002/1529-0131(200007)43:7<1520::AID-ANR16>3.3.CO
[6]  
2-H
[7]   Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases [J].
Fournié, GJ ;
Cautain, B ;
Xystrakis, E ;
Damoiseaux, J ;
Mas, M ;
Lagrange, D ;
Bernard, I ;
Subra, JF ;
Pelletier, L ;
Druet, P ;
Saoudi, A .
IMMUNOLOGICAL REVIEWS, 2001, 184 :145-160
[8]   Macrophagic myofasciitis:: an emerging entity [J].
Gherardi, RK ;
Coquet, M ;
Chérin, P ;
Authier, FJ ;
Laforêt, P ;
Bélec, L ;
Figarella-Branger, D ;
Mussini, JM ;
Pellissier, JF ;
Fardeau, M .
LANCET, 1998, 352 (9125) :347-352
[9]   Aluminum inclusion macrophagic myofasciitis: a recently identified condition [J].
Gherardi, RK ;
Authier, FJ .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2003, 23 (04) :699-+
[10]  
Gherardi RK, 2001, NEUROLOGY, V56, pA62